Given the scattered nature of the personal data in genetic research, how should the ELSI and Institutional Review Boards (IRBs) in the relevant institutions fulfill their mission? It's a tough question.
面對拼圖資料仍然稀少星散的生物資料庫與基因研究，政府與各機構的「人體試驗委員會」（IRB）該如何審查？